GoodRx Holdings Inc. announced the launch of GoodRx Employer Direct, an offering aimed at employers that combines employer-subsidized discounted cash prices for selected high-impact brand medications, including GLP-1s such as Wegovy, with customized versions of GoodRx’s condition-specific telemedicine solutions. The company said employer contributions are applied at the pharmacy counter to reduce employees’ out-of-pocket costs without adding the medication to the traditional insurance benefit. GoodRx said it began launching this model at the start of the year with its first employer partners, including Hy-Vee, with an initial focus on GLP-1 medications.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GoodRx Holdings Inc. published the original content used to generate this news brief on February 24, 2026, and is solely responsible for the information contained therein.